Angelo Antonini (University of Padova, Veneto, Italy), one of our valued European editorial board members, took the time to talk to us about the definition and management of patients with advanced Parkinson’s disease.
Questions
1. What are the key factors for the diagnosis of advanced Parkinson’s disease? (0:05)
2. Why has there been so much controversy about the definition of advanced Parkinson’s disease? (2:14)
3. What have been the most important advances in the management of patients with advanced Parkinson’s disease in the last year? (3:51)
Also see linked video: Angelo Antonini, EAN 2020 – Impulse control disorders in Parkinson’s disease
Speaker disclosure: Angelo Antonini has received honoraria for consultancies, advisory boards and/or speaker activities from: AbbVie, Bial, Boehringer Ingelheim, General Electric, NeuroDerm, UCB and Zambon. He has received research support from: Chiesi, Lundbeck, AbbVie, Horizon 2020 and MIUR.
Support: Interview and filming supported by Touch Medical Media.
Filmed at the 6th Congress of the European Academy of Neurology (EAN) and 1st EAN Virtual Congress, May 2020.
